Garg Pankaj, Singhal Gargi, Pareek Siddhika, Kulkarni Prakash, Horne David, Nath Aritro, Salgia Ravi, Singhal Sharad S
Department of Chemistry, GLA University, Mathura, Uttar Pradesh 281406, India.
Undergraduate Medical Sciences, S.N. Medical College Agra, Uttar Pradesh 282002, India.
Biochim Biophys Acta Rev Cancer. 2025 Feb;1880(1):189233. doi: 10.1016/j.bbcan.2024.189233. Epub 2024 Dec 3.
Gene editing techniques have emerged as powerful tools in biomedical research, offering precise manipulation of genetic material with the potential to revolutionize cancer treatment strategies. This review provides a comprehensive overview of the current landscape of gene editing technologies, including CRISPR-Cas systems, base editing, prime editing, and synthetic gene circuits, highlighting their applications and potential in cancer therapy. It discusses the mechanisms, advantages, and limitations of each gene editing approach, emphasizing their transformative impact on targeting oncogenes, tumor suppressor genes, and drug resistance mechanisms in various cancer types. The review delves into population-level interventions and precision prevention strategies enabled by gene editing technologies, including gene drives, synthetic gene circuits, and precision prevention tools, for controlling cancer-causing genes, targeting pre-cancerous lesions, and implementing personalized preventive measures. Ethical considerations, regulatory challenges, and future directions in gene editing research for cancer treatment are also addressed. This review highlights how gene editing could revolutionize precision medicine by enhancing patient care and advancing cancer treatments with targeted, personalized methods. For these benefits to be fully realized, collaboration among researchers, doctors, regulators, and patient advocates is crucial in fighting cancer and meeting clinical needs.
基因编辑技术已成为生物医学研究中的强大工具,能够对遗传物质进行精确操作,有望彻底改变癌症治疗策略。本综述全面概述了基因编辑技术的当前状况,包括CRISPR-Cas系统、碱基编辑、引导编辑和合成基因回路,突出了它们在癌症治疗中的应用和潜力。文中讨论了每种基因编辑方法的机制、优势和局限性,强调了它们对各种癌症类型中癌基因、肿瘤抑制基因和耐药机制的靶向作用所产生的变革性影响。该综述深入探讨了基因编辑技术所实现的群体水平干预和精准预防策略,包括基因驱动、合成基因回路和精准预防工具,用于控制致癌基因、靶向癌前病变以及实施个性化预防措施。还讨论了癌症治疗基因编辑研究中的伦理考量、监管挑战和未来方向。本综述强调了基因编辑如何通过以靶向、个性化方法加强患者护理和推进癌症治疗来彻底改变精准医学。为了充分实现这些益处,研究人员、医生、监管机构和患者权益倡导者之间的合作对于抗击癌症和满足临床需求至关重要。